Combining functionalities-nanoarchitectonics for combatting bacterial infection

New antimicrobial and anti-inflammatory therapeutics are needed because of antibiotic resistance development and resulting complications such as inflammation, ultimately leading to septic shock. The antimicrobial effects of various nanoparticles (NPs) are currently attracting intensive research interest. Although various NPs display potent antimicrobial effects against strains resistant to conventional antibiotics, the therapeutic use of such materials is restricted by poor selectivity between bacteria and human cells, leading to adverse side effects. As a result, increasing research efforts during the last few years have focused on targeting NPs against bacteria and other components in the infection micro-environment. Examples of approaches explored include peptide-, protein- and nucleic acid–based NP coatings for bacterial membrane recognition, as well as NP conjugation with enzyme substrates or other moieties that respond to bacterial or other enzymes present in the infection micro-environment. In general, this study aims to add to the literature on the antimicrobial effects of nanomaterials by discussing surface modification strategies for targeting bacterial membranes and membrane components, as well as how such surface modifications can improve the antimicrobial effects of nanomaterials and simultaneously decrease toxicity towards human cells and tissues. In doing so, the biological effects observed are related throughout to the physico-chemical modes of action underlying such effects.